Your email has been successfully added to our mailing list.

×
-0.00108015918135295 0 0.00227401932916445 0.00795906765207507 0.0090960773166572 0.00483229107447418 0.00284252416145541 -0.0045480386583285
Stock impact report

Adamas Pharma's Gocovri shows long-term treatment effect in late-stage Parkinson's study [Seeking Alpha]

Adamas Pharmaceuticals, Inc. (ADMS) 
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamaspharma.com/investors
Company Research Source: Seeking Alpha
Final results from a two-year open-label Phase 3 clinical trial, EASE LID 2 , evaluating Adamas Pharmaceuticals' ( ADMS ) GOCOVRI (amantadine) in patients with Parkinson's disease (PD) showed a sustained treatment effect. The data were presented at the International Congress of Parkinson's Disease and Movement Disorders in Hong Kong. The treatment benefit was observed in all subgroups, including those who switched to GOCOVRI from placebo or amantadine immediate release and those with uncontrollable dyskinesia after treatment with deep brain stimulation. Patients receiving GOCOVRI experienced a 35% reduction in dyskinesia and OFF periods from baseline at week 8 that was maintained for up to 100 weeks across all subgroups naïve to GOCOVRI. Over 84% of patients in the treatment group either increased or maintained their levodopa dosage for up to 100 weeks while 30% increased their doses by an average of ~300 mg/day. The FDA approved GOCOVRI in August 2017. See all Show less Read more
Impact Snapshot
Event Time:
ADMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ADMS alerts
Opt-in for
ADMS alerts

from News Quantified
Opt-in for
ADMS alerts

from News Quantified